Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2006 Feb;16(3):559-62. Epub 2005 Nov 4.

Tethering identifies fragment that yields potent inhibitors of human caspase-1.

Author information

1
Department of Chemistry, Sunesis Pharmaceuticals, 341 Oyster Point Boulevard, South San Francisco, CA 94080, USA. bfahr@sunesis.com

Abstract

Disulfide Tethering was applied to the active site of human caspase-1, resulting in the discovery of a novel, tricyclic molecular fragment that selectively binds in S4. This fragment was developed into a class of potent inhibitors of human caspase-1. Several key analogues determined the optimal distance of the tricycle from the catalytic residues, the relative importance of various features of the tricycle, and the importance of the linker.

PMID:
16274992
DOI:
10.1016/j.bmcl.2005.10.048
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center